The German Interior Ministry said on the 17th that non-EU personnel who have completed the designated new crown vaccination can enter Germany from the 25th of this month, except for those departing from areas where the mutant virus is endemic.
After the implementation of the latest entry policy, the above-mentioned personnel can easily travel or study in Germany.
According to the requirements of the Ministry of the Interior, they must complete the new crown vaccination at least 14 days before arriving in Germany.
Germany currently recognizes four new crown vaccines approved by the European Medicines Agency. They are the vaccine jointly developed by Pfizer Pharmaceuticals Co., Ltd. of the United States and the German Biotech Company, the vaccine jointly developed by AstraZeneca Pharmaceuticals of the United Kingdom and the University of Oxford, and the United States Dana’s vaccines and vaccines developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.
In order to prevent counterfeiting, Germany has made regulations on vaccine certification documents and required airlines and police to inspect them.
The number of newly confirmed cases in a single day in Germany has remained at a low level recently.
According to data released by the Robert Koch Institute, the German disease control agency, on the 18th, there were 1076 new confirmed cases of new crowns in Germany in the past 24 hours, a total of 3720031 confirmed cases, 91 new deaths and a total of 90270 deaths.